FG-3622

  • Originator F2G
  • Class Antifungals; Small molecules
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status No
  • On Fast track No

Highest Development Phases

  • Phase I Mycoses

Most Recent Events

  • 06 Jul 2009 Phase-I clinical trials in Mycoses in United Kingdom (PO)

Date of article/Start date of trial: 6 July 2009

Trial Phase: Phase 1